• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤中的热休克蛋白

Heat shock proteins in multiple myeloma.

作者信息

Zhang Lei, Fok Jacqueline H L, Davies Faith E

出版信息

Oncotarget. 2014 Mar 15;5(5):1132-48. doi: 10.18632/oncotarget.1584.

DOI:10.18632/oncotarget.1584
PMID:24675290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4012740/
Abstract

Heat shock proteins are molecular chaperones with a central role in protein folding and cellular protein homeostasis. They also play major roles in the development of cancer and in recent years have emerged as promising therapeutic targets. In this review, we discuss the known molecular mechanisms of various heat shock protein families and their involvement in cancer and in particular, multiple myeloma. In addition, we address the current progress and challenges in pharmacologically targeting these proteins as anti-cancer therapeutic strategies.

摘要

热休克蛋白是分子伴侣,在蛋白质折叠和细胞蛋白质稳态中起核心作用。它们在癌症发展中也发挥着重要作用,近年来已成为有前景的治疗靶点。在本综述中,我们讨论了各种热休克蛋白家族的已知分子机制及其在癌症特别是多发性骨髓瘤中的作用。此外,我们阐述了将这些蛋白作为抗癌治疗策略进行药物靶向的当前进展和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7298/4012740/79dee85200a9/oncotarget-05-1132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7298/4012740/cc875dd6e3d0/oncotarget-05-1132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7298/4012740/d04900e7e603/oncotarget-05-1132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7298/4012740/79dee85200a9/oncotarget-05-1132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7298/4012740/cc875dd6e3d0/oncotarget-05-1132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7298/4012740/d04900e7e603/oncotarget-05-1132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7298/4012740/79dee85200a9/oncotarget-05-1132-g003.jpg

相似文献

1
Heat shock proteins in multiple myeloma.多发性骨髓瘤中的热休克蛋白
Oncotarget. 2014 Mar 15;5(5):1132-48. doi: 10.18632/oncotarget.1584.
2
The role of heat shock protein (HSP) in atherosclerosis: Pathophysiology and clinical opportunities.热休克蛋白(HSP)在动脉粥样硬化中的作用:病理生理学和临床机遇。
Curr Med Chem. 2010;17(10):957-73. doi: 10.2174/092986710790820688.
3
[The potential role of heat shock proteins in the treatment of ovarian cancer].热休克蛋白在卵巢癌治疗中的潜在作用
Orv Hetil. 2011 Jan 16;152(3):92-5. doi: 10.1556/OH.2011.29024.
4
HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).热休克蛋白27、70和90,抗凋亡蛋白,在临床癌症治疗中(综述)
Int J Oncol. 2014 Jul;45(1):18-30. doi: 10.3892/ijo.2014.2399. Epub 2014 Apr 25.
5
Heat shock proteins and kidney disease: perspectives of HSP therapy.热休克蛋白与肾脏疾病:热休克蛋白治疗的前景
Cell Stress Chaperones. 2017 May;22(3):319-343. doi: 10.1007/s12192-017-0790-0. Epub 2017 Apr 13.
6
The maximal cytoprotective function of the heat shock protein 27 is dependent on heat shock protein 70.热休克蛋白27的最大细胞保护功能依赖于热休克蛋白70。
Biochim Biophys Acta. 2011 Jan;1813(1):129-35. doi: 10.1016/j.bbamcr.2010.08.012. Epub 2010 Oct 8.
7
Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.热休克蛋白和热休克因子 1 在致癌作用和肿瘤发展中的作用:最新研究进展。
Arch Toxicol. 2013 Jan;87(1):19-48. doi: 10.1007/s00204-012-0918-z. Epub 2012 Aug 11.
8
ClpB and HtpG facilitate de novo protein folding in stressed Escherichia coli cells.ClpB和HtpG有助于应激条件下的大肠杆菌细胞中的新生蛋白质折叠。
Mol Microbiol. 2000 Jun;36(6):1360-70. doi: 10.1046/j.1365-2958.2000.01951.x.
9
Regulation of the heat shock response under anoxia in the turtle, Trachemys scripta elegans.缺氧条件下龟(Trachemys scripta elegans)热休克反应的调控。
J Comp Physiol B. 2010 Mar;180(3):403-14. doi: 10.1007/s00360-009-0414-9. Epub 2009 Oct 16.
10
Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?靶向 HSP70:第二个潜在可成药的热休克蛋白和分子伴侣?
Cell Cycle. 2010 Apr 15;9(8):1542-50. doi: 10.4161/cc.9.8.11204.

引用本文的文献

1
Heat Shock Protein and Disaggregase Influencing the Casein Structuralisation.热休克蛋白与解聚酶对酪蛋白结构形成的影响
Int J Mol Sci. 2025 Jul 1;26(13):6360. doi: 10.3390/ijms26136360.
2
Impact of proteostasis workload on sensitivity to proteasome inhibitors in multiple myeloma.蛋白质稳态工作负荷对多发性骨髓瘤中蛋白酶体抑制剂敏感性的影响
Clin Exp Med. 2025 May 26;25(1):176. doi: 10.1007/s10238-025-01713-z.
3
Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways.

本文引用的文献

1
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX.热休克蛋白90(HSP90)抑制剂17-AAG(坦螺旋霉素)诱导的细胞死亡模式取决于促凋亡蛋白BAX的表达。
Oncotarget. 2013 Nov;4(11):1963-75. doi: 10.18632/oncotarget.1419.
2
Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation.细胞应激反应和先天免疫信号:整合宿主防御和炎症中的途径。
J Leukoc Biol. 2013 Dec;94(6):1167-84. doi: 10.1189/jlb.0313153. Epub 2013 Aug 29.
3
Inhibition of HSP90 molecular chaperones: moving into the clinic.
神经退行性疾病中的错误折叠和聚集:蛋白质质量控制机制作为潜在的治疗性清除途径。
Cell Commun Signal. 2024 Aug 30;22(1):421. doi: 10.1186/s12964-024-01791-8.
4
Modeling cell populations metabolism and competition under maximum power constraints.在最大功率约束下对细胞群体代谢和竞争进行建模。
PLoS Comput Biol. 2023 Nov 8;19(11):e1011607. doi: 10.1371/journal.pcbi.1011607. eCollection 2023 Nov.
5
Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway.多发性骨髓瘤中的可变剪接与非同源末端连接途径有关。
Blood Cancer J. 2023 Jan 20;13(1):16. doi: 10.1038/s41408-023-00783-0.
6
HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma.HSPB11是一种与肝细胞癌免疫浸润相关的预后生物标志物。
Int J Gen Med. 2022 Apr 13;15:4017-4027. doi: 10.2147/IJGM.S363679. eCollection 2022.
7
Overcoming drug resistance by targeting protein homeostasis in multiple myeloma.通过靶向多发性骨髓瘤中的蛋白质稳态克服耐药性。
Cancer Drug Resist. 2021;4(4):1028-1046. doi: 10.20517/cdr.2021.93. Epub 2021 Dec 2.
8
Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma.警报素在多发性骨髓瘤的发病机制和进展中的作用。
Int J Mol Sci. 2021 Aug 21;22(16):9039. doi: 10.3390/ijms22169039.
9
Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.靶向线粒体 HSPD1 导致非小细胞肺癌代谢损伤。
J Exp Clin Cancer Res. 2021 Aug 7;40(1):248. doi: 10.1186/s13046-021-02049-8.
10
Transferrin Modified GSH Sensitive Hyaluronic Acid Derivative Micelle to Deliver HSP90 Inhibitors to Enhance the Therapeutic Efficacy of Brain Cancers.转铁蛋白修饰的谷胱甘肽敏感型透明质酸衍生物胶束用于递送热休克蛋白90抑制剂以增强脑癌治疗效果。
Cancers (Basel). 2021 May 14;13(10):2375. doi: 10.3390/cancers13102375.
抑制 HSP90 分子伴侣:走向临床。
Lancet Oncol. 2013 Aug;14(9):e358-69. doi: 10.1016/S1470-2045(13)70169-4.
4
Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress.热休克蛋白 70 抑制通过细胞内免疫球蛋白的积累和产生蛋白毒性应激诱导骨髓瘤细胞死亡。
Cancer Lett. 2013 Oct 1;339(1):49-59. doi: 10.1016/j.canlet.2013.07.023. Epub 2013 Jul 22.
5
Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors.热休克蛋白90的翻译后修饰和构象状态对化学结构多样的小分子抑制剂的结合有不同影响。
Oncotarget. 2013 Jul;4(7):1065-74. doi: 10.18632/oncotarget.1099.
6
Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3.细胞外 HSP27 通过 Toll 样受体 3 介导血管生成。
FASEB J. 2013 Oct;27(10):4169-83. doi: 10.1096/fj.12-226977. Epub 2013 Jun 26.
7
Phase I trial of the HSP90 inhibitor PF-04929113 (SNX5422) in adult patients with recurrent, refractory hematologic malignancies.PF-04929113(SNX5422)在复发/难治性血液系统恶性肿瘤成人患者中的 I 期临床试验。
Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):385-91. doi: 10.1016/j.clml.2013.03.010. Epub 2013 Jun 10.
8
The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase.线粒体伴侣蛋白 TRAP1 通过抑制琥珀酸脱氢酶促进肿瘤生长。
Cell Metab. 2013 Jun 4;17(6):988-999. doi: 10.1016/j.cmet.2013.04.019.
9
The monomeric receptor binding domain of tetrameric α2-macroglobulin binds to cell surface GRP78 triggering equivalent activation of signaling cascades.四聚体α2-巨球蛋白的单体受体结合域与细胞表面 GRP78 结合,触发信号级联的等效激活。
Biochemistry. 2013 Jun 11;52(23):4014-25. doi: 10.1021/bi400376s. Epub 2013 May 30.
10
Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application.了解蛋白酶体途径与自噬之间在骨髓瘤细胞中对双重PI3K/mTOR抑制的反应中的相互作用,对于它们的有效临床应用至关重要。
Leukemia. 2013 Dec;27(12):2397-403. doi: 10.1038/leu.2013.150. Epub 2013 May 14.